Identify stocks that meet your criteria using seven unique stock screeners. The average TherapeuticsMD stock price prediction forecasts a potential downside of N/A from the current TXMD share price of $1.06. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. See what's happening in the market right now with MarketBeat's real-time news feed. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. CloudMD Software & Services Inc Forecast, Short-Term " DOCRF" Stock Price Prognosis for Next Days Walletinvestor.com DOCRF Forecast, Long-Term Price Predictions for Next Months and Year: 2021, 2022 CloudMD Software & Services has received 100.00% “outperform” votes from our community. View analyst ratings for CloudMD Software & Services or view top-rated stocks. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Fundamental company data provided by Zacks Investment Research. CloudMD Software & Services (DOCRF) stock price prediction is 8.03286 USD. On average, they expect CloudMD Software & Services' stock price to reach $3.38 in the next year. The average price target is C$3.74 with a high forecast of C$3.99 and a low forecast of C$3.49. CloudMD Software & Servi... share price and DOC stock charts. CloudMD stock has soared more than 200% since its debut at TSXV in June of this year. The company offers SAAS based health technology solutions to medical clinics across Canada and has developed proprietary technology to deliver quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). MarketBeat's community ratings are surveys of what our community members think about CloudMD Software & Services and other stocks. Free forex prices, toplists, indices and lots more. MarketBeat just released five new stock ideas, but CloudMD Software & Services wasn't one of them. This suggests a possible upside of 120.2% from the stock's current price. This price target is based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. 4th May - Ben Hobson As any reader of this is probably aware, shares in CloudMD Software & Services Inc (CNSX:DOC) are currently trading close to a 52 week high, with the share price up by around 31.3% to 0.84 over the past week. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. This is slightly up from the average last month, which was C$3.45. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. The average price target represents a … Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. On average, they expect CloudMD Software & Services' stock price to reach C$3.88 in the next twelve months. An entirely new—and highly profitable—industry is being borne out in 2020— TeleHealth. The successful prediction of Cloudmd Software stock future price could yield a significant profit. This suggests a possible upside of 112.3% from the stock's current price. (NASDAQ: TXMD) TherapeuticsMD's current Earnings Per Share (EPS) is -$0.57. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View all of DOCRF's competitors. CloudMD (DOC-CSE) is my favourite way to play Tele-Health. ET). It is a grow company and the telemedicine sector will be the future. ET) and the After Hours Market (4:00-8:00 p.m. CloudMD Software & Services Inc (DOCRF) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent. In the past three months, CloudMD Software & Services insiders have not sold or bought any company stock. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. MarketBeat thinks these five companies may be even better buys.View MarketBeat's top stock picks here. CloudMD stock is currently trading at a price-to-sales ratio of 31.2. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Get daily stock ideas top-performing Wall Street analysts. Find real-time DOCRF - CloudMD Software & Services Inc stock quotes, company profile, news and forecasts from CNN Business. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. This suggests a possible upside of 94.7% from the stock's current price. By clicking "Accept all" you agree that Verizon Media and our partners will store and/or access information on your device through the use of cookies and similar technologies and process your personal data, to display personalised ads and content, for ad and content measurement, audience insights and product development. CloudMD Software & Services does not have a long track record of dividend growth. Looking for new stock ideas? View which stocks are hot on social media with MarketBeat's trending stocks report. Vote “Underperform” if you believe DOCRF will underperform the S&P 500 over the long term. On 2021-05-14, CloudMD (DOC-X) stock closed at a price of $1.95. (82.32% Upside) Based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. The average price target represents a 88.11% upside from the last price of C$2.06. CloudMD Software & Services has received 11 “outperform” votes. CloudMD Software & Services Inc stock and Healthcare market discussion, news, and analysis from Canada's largest community of active investors Stockhouse.com use cookies on this site. ), CloudMD Software & Services has received 0 “underperform” votes. Prior to the recent declines in stock prices experienced by WELL Health and CloudMD, both companies had been performing extremely well in 2020. CloudMD Software & Services has only been the subject of 1 research reports in the past 90 days. Export data to Excel for your own analysis. Based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. Wall Street analysts have given CloudMD Software & Services a "Buy" rating, but there may be better buying opportunities in the stock market. You may vote once every thirty days. CloudMD Software & Services does not currently pay a dividend. CloudMD has access to Rxi’s network of 500 independent pharmacies to provide better, more localized, access to care. View real-time stock prices and stock quotes for a full financial overview. By continuing to use our service, you agree to our use of cookies. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. CloudMD: Canaccord Raises Price Target To $3.75. Shares have increased by 130% in one month. Average Price Target. CloudMD is part of CloudMD Software & Services Inc.. MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. The average price target represents a 103.31% upside from the last price of $1.66. View our full suite of financial calendars and market data tables, all for free. What is TXMD's Earnings Per Share (EPS) forecast for 2021-2023? Want to see which stocks are moving? How has CloudMD Software & Services's share price performed over time and what events caused price changes? Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. CloudMD Software & Services' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Blowout Results May Not Sustain Target’s Rally, Under Armour Shares Gap Lower As Judge OK's Shareholder Lawsuit, The Container Store Has What Every Growth Stocks Needs, Don’t Rush To Buy Walmart, Extra Low Prices Are On The Way, Legal Issues Behind It, IBIO Stock May Be a Long Play For Risk-Tolerant Investors, Steel Producers Extend Their One-Year Gains On Strong Demand, Lumentum Stock Providing Opportunistic Pullbacks, 7 Cyclical Stocks That Can Help You Play Defense, 7 Stocks That Could Benefit From a Capital Gains Tax Hike, 7 Forever Stocks That Are Never Bad to Buy, 7 Stocks That Still Have Upside For Investors to Buy, 7 Precious Metals Stocks That Will Keep Your Portfolio On Trend, 7 Bellwether Stocks Signaling a Return to Normal, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, CloudMD Closes Acquisition of Rxi, Providing an Established Specialty Drug Management and Patient Support Program to the Employer Market, CloudMD Software & Services (OTCMKTS:DOCRF) Trading Up 3.3%, Cloudmd Software & Services Inc. (DOC-X) Quote - Press Release - The Globe and Mail, CloudMD Reports Record Fourth Quarter 2020 Revenue; On Track for Significant Growth in 2021, CloudMD to Participate in Upcoming Laurentian Bank and Bloom Burton & Co. Investor Conferences, CloudMD Announces Rapid Growth of Enterprise Health Solutions Division, CloudMD Announces Closing of $8.2 Million Over-Allotment Option, CloudMD Announces Closing of $8.2 Million Over-Allotment Option, CloudMD Announces Closing of $55 Million Bought Deal Financing, Medavie Blue Cross partners with Medical Confidence to create new way to support Canadians on disability waiting for a specialist, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily.
St Patrick's Day 2021 Madison, Wi, Prediksi Ekonomi Indonesia 2021, Basic Fsa Debit Card, Eurovision 2021 Scoreboard, Premier League 2 Division 3 Table, Bacarra Church History, Quarkchain Price Prediction 2030, Gregorian Monks Singing Pop Songs, Patience Release Date Ksi, Videos Keep Pausing Every Few Seconds Windows 10, Cards Like Bloodmoon, Alex Neil Hearts, Two Cusped Arch,
